A detailed history of Comerica Bank transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Comerica Bank holds 53,189 shares of PCRX stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,189
Previous 67,907 21.67%
Holding current value
$1.04 Million
Previous $1.94 Million 58.75%
% of portfolio
0.0%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.7 - $28.46 $172,200 - $418,874
-14,718 Reduced 21.67%
53,189 $801,000
Q2 2024

Aug 15, 2024

SELL
$25.5 - $31.51 $610,113 - $753,908
-23,926 Reduced 26.05%
67,907 $1.94 Million
Q1 2024

May 15, 2024

BUY
$27.7 - $35.48 $1.88 Million - $2.41 Million
68,027 Added 285.76%
91,833 $2.68 Million
Q4 2023

Feb 14, 2024

BUY
$26.32 - $34.31 $19,029 - $24,806
723 Added 3.13%
23,806 $803,000
Q3 2023

Nov 21, 2023

BUY
$30.68 - $40.09 $708,186 - $925,397
23,083 New
23,083 $708,000
Q4 2022

Jan 26, 2023

SELL
$38.19 - $57.45 $302,312 - $454,774
-7,916 Reduced 22.32%
27,544 $0
Q3 2022

Oct 28, 2022

SELL
$51.24 - $58.89 $187,026 - $214,948
-3,650 Reduced 9.33%
35,460 $1.84 Million
Q2 2022

Aug 02, 2022

BUY
$51.49 - $81.64 $16,734 - $26,533
325 Added 0.84%
39,110 $2.12 Million
Q1 2022

Apr 27, 2022

BUY
$60.03 - $76.49 $56,248 - $71,671
937 Added 2.48%
38,785 $2.96 Million
Q4 2021

Feb 18, 2022

SELL
$47.97 - $62.21 $134,555 - $174,499
-2,805 Reduced 6.9%
37,848 $2.28 Million
Q3 2021

Nov 22, 2021

SELL
$54.64 - $61.3 $48,247 - $54,127
-883 Reduced 2.13%
40,653 $2.28 Million
Q2 2021

Aug 26, 2021

SELL
$59.18 - $69.99 $180,617 - $213,609
-3,052 Reduced 6.84%
41,536 $2.52 Million
Q1 2021

Apr 28, 2021

SELL
$59.31 - $78.82 $84,220 - $111,924
-1,420 Reduced 3.09%
44,588 $3.13 Million
Q4 2020

Jan 28, 2021

BUY
$50.47 - $66.26 $49,410 - $64,868
979 Added 2.17%
46,008 $2.75 Million
Q3 2020

Oct 30, 2020

BUY
$51.97 - $63.0 $9,458 - $11,466
182 Added 0.41%
45,029 $2.71 Million
Q2 2020

Jul 31, 2020

BUY
$30.8 - $52.47 $121,968 - $207,781
3,960 Added 9.69%
44,847 $2.35 Million
Q1 2020

May 01, 2020

BUY
$28.4 - $50.7 $42,344 - $75,593
1,491 Added 3.78%
40,887 $1.37 Million
Q4 2019

Feb 07, 2020

BUY
$36.31 - $46.83 $1.43 Million - $1.84 Million
39,396 New
39,396 $1.78 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.